TNFRSF8 and lymphoma: After binding to CD30+ HL cells, anti-CD30-IL-2 or anti-CD30-IL-12, antibody-cytokine fusion proteins were able to induce resting NK cells, but not T cells, to lyse the lymphoma cells with very high efficiency [58, 59].